In support of RhoC as a mediator of chemoresistance, Kawata and colleagues separately found that RhoC protein expression was significantly higher in breast tumor tissue after chemotherapy compared with tumor tissue taken before therapy [113]. This evidence concerns the gene RHOC and breast neoplasm.